Galangin suppresses the proliferation of β-catenin response transcription-positive cancer cells by promoting adenomatous polyposis coli/axin/glycogen synthase kinase-3β-independent β-catenin degradation

Molecular Pharmacology

Volumn 79, Issue 6, 2011, Pages 1014-1022

  Gwak, Jungsug ^a,b   Oh, Jingyo ^a   Cho, Munju ^a   Bae, Soo Kyung ^c   Song, Im Sook ^a   Liu, Kwang Hyeon ^a,d   Jeong, Yongsu ^e   Kim, Dong Eun ^f   Chung, Young Hwa ^g   Oh, Sangtaek ^a,b  

^a Inje University   (South Korea)

^b Kookmin University   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Kyungpook National University   (South Korea)

^e Kyung Hee University   (South Korea)

^f Konkuk University   (South Korea)

^g Pusan National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; AXIN; BETA CATENIN; CYCLIN D1; GALANGIN; GLYCOGEN SYNTHASE KINASE 3BETA; HYDROXYL GROUP; T CELL FACTOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL PROLIFERATION; COLORECTAL CANCER; DOWN REGULATION; DRUG SCREENING; GENE; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIVER CANCER; MUTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOMATOUS POLYPOSIS COLI PROTEIN; BETA CATENIN; CELL LINE; CELL PROLIFERATION; DOWN-REGULATION; FLAVONOIDS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; HYDROLYSIS; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC;

EID: 79956296141     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.110.069591     Document Type: Article

References (39)

1. Aberle H, Bauer A, Stappert J, Kispert A, and Kemler R (1997) β-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16:3797-3804.
2. Amoros M, Simões CM, Girre L, Sauvager F, and Cormier M (1992) Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture. Comparison with the antiviral activity of propolis. J Nat Prod 55:1732-1740. (Pubitemid 23023259)
3. Bestwick CS and Milne L (2006) Influence of galangin on HL-60 cell proliferation and survival. Cancer Lett 243:80-89. (Pubitemid 44485322)
4. Chen B, Dodge ME, Tang W, Lu J, Ma Z, Fan CW, Wei S, Hao W, Kilgore J, Williams NS, et al. (2009) Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol 5:100-107.
5. Cho M, Gwak J, Park S, Won J, Kim DE, Yea SS, Cha IJ, Kim TK, Shin JG, and Oh S (2005) Diclofenac attenuates Wnt/β-catenin signaling in colon cancer cells by activation of NF-κB. FEBS Lett 579:4213-4218. (Pubitemid 41121964)
6. Dignam JD, Lebovitz RM, and Roeder RG (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1489.
7. Fearnhead NS, Britton MP, and Bodmer WF (2001) The ABC of APC. Hum Mol Genet 10:721-733. (Pubitemid 32331581)
8. Giles RH, van Es JH, and Clevers H (2003) Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys Acta 1653:1-24. (Pubitemid 36627817)
9. Green DW, Roh H, Pippin JA, and Drebin JA (2001) β-Catenin antisense treatment decreases β-catenin expression and tumor growth rate in colon carcinoma xenografts. J Surg Res 101:16-20. (Pubitemid 33030101)
10. Hart M, Concordet JP, Lassot I, Albert I, del los Santos R, Durand H, Perret C, Rubinfeld B, Margottin F, Benarous R, et al. (1999) The F-box protein β-TrCP associates with phosphorylated β-catenin and regulates its activity in the cell. Curr Biol 9:207-210.
11. Hart MJ, de los Santos R, Albert IN, Rubinfeld B, and Polakis P (1998) Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3β. Curr Biol 8:573-581.
12. He TC, Chan TA, Vogelstein B, and Kinzler KW (1999) PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99:335-345. (Pubitemid 29519912)
13. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, and Kinzler KW (1998) Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512. (Pubitemid 28425575)
14. Heo MY, Sohn SJ, and Au WW (2001) Anti-genotoxicity of galangin as a cancer chemopreventive agent candidate. Mutat Res 488:135-150. (Pubitemid 32436428)
15. Heo MY, Yu KS, Kim KH, Kim HP, and Au WW (1992) Anticlastogenic effect of flavonoids against mutagen-induced micronuclei in mice. Mutat Res 284:243-249.
16. Huang SM, Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud GA, Charlat O, Wiellette E, Zhang Y, Wiessner S, et al. (2009) Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461:614-620.
17. Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, and Kikuchi A (1998) Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO J 17:1371-1384. (Pubitemid 28105516)
18. Ilyas M, Tomlinson IP, Rowan A, Pignatelli M, and Bodmer WF (1997) β-Catenin mutations in cell lines established from human colorectal cancers. Proc Natl Acad Sci USA 94:10330-10334. (Pubitemid 27407041)
19. Imamura Y, Migita T, Uriu Y, Otagiri M, and Okawara T (2000) Inhibitory effects of flavonoids on rabbit heart carbonyl reductase. J Biochem 127:653-658. (Pubitemid 30238359)
20. Karim R, Tse G, Putti T, Scolyer R, and Lee S (2004) The significance of the Wnt pathway in the pathology of human cancers. Pathology 36:120-128. (Pubitemid 38507872)
21. Klein PS and Melton DA (1996) A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93:8455-8459. (Pubitemid 26269579)
22. Liu J, Stevens J, Rote CA, Yost HJ, Hu Y, Neufeld KL, White RL, and Matsunami N (2001) Siah-1 mediates a novel β-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol Cell 7:927-936. (Pubitemid 32525740)
23. Matsuzawa SI and Reed JC (2001) Siah-1, SIP, and Ebi collaborate in a novel pathway for β-catenin degradation linked to p53 responses. Mol Cell 7:915-926.
24. Miyoshi Y, Iwao K, Nagasawa Y, Aihara T, Sasaki Y, Imaoka S, Murata M, Shimano T, and Nakamura Y (1998) Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res 58:2524-2527. (Pubitemid 28275419)
25. Morin PJ (1999) β-Catenin signaling and cancer. Bioessays 21:1021-1030.
26. Murray TJ, Yang X, and Sherr DH (2006) Growth of a human mammary tumor cell line is blocked by galangin, a naturally occurring bioflavonoid, and is accompanied by down-regulation of cyclins D3, E, and A. Breast Cancer Res 8:R17.
27. O'Leary KA, de Pascual-Tereasa S, Needs PW, Bao YP, O'Brien NM, and Williamson G (2004) Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutat Res 551:245-254. (Pubitemid 38833512)
28. Park S, Gwak J, Cho M, Song T, Won J, Kim DE, Shin JG, and Oh S (2006) Hexachlorophene inhibits Wnt/β-catenin pathway by promoting Siah-mediated β-catenin degradation. Mol Pharmacol 70:960-966. (Pubitemid 44268452)
29. Peifer M and Polakis P (2000) Wnt signaling in oncogenesis and embryogenesis-a look outside the nucleus. Science 287:1606-1609. (Pubitemid 30127755)
30. Quadri SA, Qadri AN, Hahn ME, Mann KK, and Sherr DH (2000) The bioflavonoid galangin blocks aryl hydrocarbon receptor activation and polycyclic aromatic hydrocarbon-induced pre-B cell apoptosis. Mol Pharmacol 58:515-525.
31. Roh H, Green DW, Boswell CB, Pippin JA, and Drebin JA (2001) Suppression of β-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells. Cancer Res 61:6563-6568. (Pubitemid 32783265)
32. Ryu MJ, Cho M, Song JY, Yun YS, Choi IW, Kim DE, Park BS, and Oh S (2008) Natural derivatives of curcumin attenuate the Wnt/β-catenin pathway through down-regulation of the transcriptional coactivator p300. Biochem Biophys Res Commun 377:1304-1308.
33. Sharma C, Pradeep A, Wong L, Rana A, and Rana B (2004) Peroxisome proliferator-activated receptor γ activation can regulate β-catenin levels via a proteasome-mediated and adenomatous polyposis coli-independent pathway. J Biol Chem 279:35583-35594. (Pubitemid 39100560)
34. Takahashi M, Tsunoda T, Seiki M, Nakamura Y, and Furukawa Y (2002) Identification of membrane-type matrix metalloproteinase-1 as a target of the β-catenin/Tcf4 complex in human colorectal cancers. Oncogene 21:5861-5867. (Pubitemid 35007236)
35. Tetsu O and McCormick F (1999) β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422-426. (Pubitemid 29180374)
36. Verma UN, Surabhi RM, Schmaltieg A, Becerra C, and Gaynor RB (2003) Small interfering RNAs directed against β-catenin inhibit the in vitro and in vivo growth of colon cancer cells. Clin Cancer Res 9:1291-1300. (Pubitemid 36418379)
37. Wodarz A and Nusse R (1998) Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14:59-88. (Pubitemid 29001449)
38. Xiao JH, Ghosn C, Hinchman C, Forbes C, Wang J, Snider N, Cordrey A, Zhao Y, and Chandraratna RA (2003) Adenomatous polyposis coli (APC)-independent regulation of β-catenin degradation via a retinoid X receptor-mediated pathway. J Biol Chem 278:29954-29962. (Pubitemid 36962384)
39. Zhai S, Dai R, Friedman FK, and Vestal RE (1998) Comparative inhibition of human cytochromes P450 1A1 and 1A2 by flavonoids. Drug Metab Dispos 26:989-992. (Pubitemid 28478260)